Ind-Swift Laboratories Limited (BOM:532305)
India · Delayed Price · Currency is INR 135.80
+0.70 (0.52%)
At close: Feb 13, 2026
Ind-Swift Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 5,938 | 5,617 | 17,091 | 12,073 | 10,387 | 8,913 |
Other Revenue | - | - | - | 86.24 | 141.74 | 154.32 |
Revenue | 5,938 | 5,617 | 17,091 | 12,159 | 10,529 | 9,068 |
Revenue Growth (YoY) | 28.12% | -67.14% | 40.56% | 15.48% | 16.11% | 13.44% |
Cost of Revenue | 2,780 | 2,880 | 8,698 | 6,556 | 5,374 | 4,514 |
Gross Profit | 3,158 | 2,738 | 8,393 | 5,604 | 5,155 | 4,553 |
Selling, General & Admin | 1,397 | 1,252 | 2,475 | 1,401 | 1,278 | 1,079 |
Other Operating Expenses | 1,760 | 1,680 | 2,856 | 1,814 | 1,642 | 1,492 |
Operating Expenses | 3,456 | 3,176 | 6,135 | 3,788 | 4,231 | 3,444 |
Operating Income | -298.58 | -438.59 | 2,259 | 1,815 | 924.23 | 1,110 |
Interest Expense | - | -13.83 | -977.96 | -863.93 | -914.53 | -933.53 |
Interest & Investment Income | 627.23 | 382.69 | 100.49 | 58.72 | 5.62 | 5.13 |
Earnings From Equity Investments | 0.87 | -0.52 | -4.9 | -2.34 | - | - |
Currency Exchange Gain (Loss) | 103.09 | 103.09 | 163.5 | 180.87 | 147.63 | 32.72 |
Other Non Operating Income (Expenses) | -143.68 | 25.36 | 121.22 | -48.57 | 99.03 | -33.83 |
EBT Excluding Unusual Items | 288.93 | 58.2 | 1,661 | 1,140 | 261.99 | 180.09 |
Gain (Loss) on Sale of Investments | - | - | 434.71 | - | - | - |
Gain (Loss) on Sale of Assets | 287.22 | 287.22 | -28.41 | -0.61 | -65.66 | - |
Asset Writedown | - | - | - | -10 | -71.01 | - |
Other Unusual Items | 2,100 | 2,232 | 3,910 | -266.48 | - | - |
Pretax Income | 2,676 | 2,577 | 5,977 | 862.87 | 125.33 | 180.09 |
Income Tax Expense | 190.69 | 72.7 | 589.81 | 386.9 | 146.82 | 211.56 |
Net Income | 2,486 | 2,505 | 5,388 | 475.97 | -21.49 | -31.47 |
Net Income to Common | 2,486 | 2,505 | 5,388 | 475.97 | -21.49 | -31.47 |
Net Income Growth | -29.78% | -53.51% | 1031.91% | - | - | - |
Shares Outstanding (Basic) | 78 | 67 | 59 | 59 | 59 | 59 |
Shares Outstanding (Diluted) | 79 | 71 | 59 | 59 | 59 | 59 |
Shares Change (YoY) | 34.59% | 20.41% | - | - | - | 19.46% |
EPS (Basic) | 31.89 | 37.25 | 91.18 | 8.06 | -0.36 | -0.53 |
EPS (Diluted) | 31.33 | 35.21 | 91.18 | 8.06 | -0.36 | -0.53 |
EPS Growth | -47.82% | -61.38% | 1031.91% | - | - | - |
Free Cash Flow | - | -898.8 | -2,600 | 1,818 | 1,319 | 1,310 |
Free Cash Flow Per Share | - | -12.63 | -44.00 | 30.78 | 22.32 | 22.18 |
Gross Margin | 53.18% | 48.74% | 49.11% | 46.08% | 48.96% | 50.21% |
Operating Margin | -5.03% | -7.81% | 13.21% | 14.93% | 8.78% | 12.24% |
Profit Margin | 41.86% | 44.59% | 31.52% | 3.91% | -0.20% | -0.35% |
Free Cash Flow Margin | - | -16.00% | -15.21% | 14.95% | 12.52% | 14.45% |
EBITDA | -515.21 | -217.76 | 3,063 | 2,389 | 2,235 | 1,983 |
EBITDA Margin | -8.68% | -3.88% | 17.92% | 19.64% | 21.22% | 21.86% |
D&A For EBITDA | -216.62 | 220.83 | 804.1 | 573.39 | 1,310 | 872.92 |
EBIT | -298.58 | -438.59 | 2,259 | 1,815 | 924.23 | 1,110 |
EBIT Margin | -5.03% | -7.81% | 13.21% | 14.93% | 8.78% | 12.24% |
Effective Tax Rate | 7.12% | 2.82% | 9.87% | 44.84% | 117.15% | 117.48% |
Revenue as Reported | 6,583 | 6,431 | 17,975 | 12,408 | 10,822 | 9,140 |
Advertising Expenses | - | 60.16 | 84.09 | 34.92 | 2.36 | 7.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.